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Introduction
Patients with epilepsy have a high risk of sudden death (1). The 
underlying mechanisms of this sudden unexplained death in epi-
lepsy (SUDEP) are unknown, but it is believed that most deaths 
occur immediately after a seizure (2, 3). To identify premorbid bio-
markers of patients at highest risk for SUDEP, to develop targeted 
preventative treatments, and to recommend effective methods for 
rescuing patients from near-SUDEP, it is necessary to define the 
sequence of events that leads from a seizure to death.
A variety of mechanisms have been proposed for SUDEP (1, 2, 4–
6), including cardiac arrhythmias (7–10), dysfunction of autonomic 
control (11–15), apnea/hypoventilation (3, 16–21), airway obstruction 
(22), pulmonary edema (23), brain stem spreading depolarization 
(BSD) (24), and postictal generalized EEG suppression (PGES) (25). 
Many investigators have focused on cardiac tachyarrhythmias as the 
cause of death, in part because of an association between SUDEP 
and mutations of genes expressed in the heart, such as those that 
underlie long QT syndrome (10, 26–28). In some cases these muta-
tions may cause both arrhythmias and seizures (10, 29, 30), whereas 
in other cases the mutations may predispose patients to arrhyth-
mias if they have seizures due to other reasons. In patients who are 
monitored in epilepsy monitoring units (EMUs), nonfatal seizures 
can sometimes induce bradycardia, asystole, O2 desaturation, or 
apnea (4, 5, 8, 16, 17). A small number of patients (n = 11) who died of 
SUDEP while being monitored in EMUs was recently reported (2). 
In those patients, the typical sequence of events was a generalized 
tonic-clonic seizure followed by bradycardia and asystole (2), along 
with decreased respiratory rate leading to terminal apnea. For those 
patients, measurements of blood pressure, ventilation, CO2 levels, or 
O2 saturation were not made, so there are still important unanswered 
questions about mechanisms, such as whether there was hypoten-
sion or whether lung inflation was effective. It is also not clear what 
happened during the seizures, as respiratory movements and the 
ECG were obscured by convulsive movements. Most of the moni-
tored patients who experienced SUDEP had temporal lobe epilepsy, 
so it is not clear whether those data are relevant to SUDEP in patients 
with other types of epilepsy. However, all of these SUDEP cases 
involved terminal apnea first, followed by terminal asystole.
Dravet syndrome (DS) is an intractable epileptic encephalop-
athy in which febrile seizures typically appear in the first 6 to 12 
months of life, followed by other types of severe, refractory sei-
zures and cognitive impairment (31). In 70%–95% of cases, DS is 
due to mutations of SCN1A (32–34), which encodes the sodium 
channel Nav1.1. SUDEP is particularly common in patients with 
DS, causing death in 5%–10% of cases, most commonly during the 
first few years of life (31, 35, 36).
Clinical data have pointed to cardiac mechanisms being 
important for SUDEP in DS. For example, mutations of SCN1A in 
patients with DS cause increased QT and P wave dispersion and 
a decrease in heart rate variability (HRV) (12, 37). However, there 
are no published reports of ECG changes after fatal or nonfatal 
generalized seizures in patients with DS, other than a single case 
report after status epilepticus (38). Peri-ictal breathing has not 
been measured in patients with DS.
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is due to increased vagal output to the heart (40). However, 
breathing measurements were not made during spontaneous or 
heat-induced seizures in either of these DS mouse models, so it 
is unclear whether abnormal breathing contributes to SUDEP. 
Here we studied patients with DS and mice with an Scn1aR1407X/+ 
mutation (39) to evaluate a potential role of postictal breathing 
dysfunction in SUDEP.
Results
Peri-ictal respiratory dysfunction was common in patients with DS. 
Video recordings of generalized seizures from 7 patients with DS 
and 7 patients with localization-related epilepsy were reviewed 
by an investigator (G.B. Richerson) blind to the cause of epilepsy. 
Visualization of chest and abdomen movements, aided by Eule-
rian video magnification (44), was used to evaluate breathing 
frequency and pattern (see Methods; Supplemental Figure 1; sup-
plemental material available online with this article; https://doi.
org/10.1172/JCI94999DS1). Patients with DS were significantly 
more likely to have peri-ictal abnormal breathing consistent with 
disturbances of respiratory rhythm generation or patterned out-
put (Table 1; P = 0.018, χ2 test), including paradoxical breathing, 
inspiratory efforts with 2 or 3 peaks, ataxic breathing, or apnea of 
5 seconds or longer (Figure 1, Supplemental Figure 2, and Supple-
mental Videos 1 and 2). Many patients produced loud upper air-
way sounds consistent with obstruction, but this was not signifi-
cantly more common in either group (Table 1). In all of these cases, 
breathing abnormalities were transient.
Video recordings can reveal valuable information about peri-
ictal respiratory patterns, but as was true for previously reported 
EMU recordings (2), this approach leaves many unanswered 
questions (see Introduction). To more accurately characterize 
the abnormalities of peri-ictal breathing, a 9-year-old girl with 
DS and an associated de novo missense mutation of SCN1A was 
admitted for recording of video EEG, which was supplemented 
with recordings of respiratory impedance plethysmography and 
transcutaneous CO2 (tcCO2) (Figure 2). The patient had 3 con-
Mouse models of DS have been generated by knockout of 
Scn1a, or with mutations such as R1407X, which is seen in some 
patients and leads to truncation of Nav1.1 and functional inacti-
vation (39). The phenotype of the Scn1aR1407X/+ mutation and the 
Scn1a knockout are similar and recapitulate the phenotype of DS 
in humans (31), including seizures that occur spontaneously and 
in response to hyperthermia (7, 39, 40). Heat-induced seizures 
in DS mice are often followed by death (7, 40). In addition to the 
brain, Nav1.1 is expressed in the heart, including the sinoatrial 
node (41) and cardiac T tubules (42). Mice with an Scn1aR1407X/+ 
mutation have cardiac myocyte dysfunction and die spontane-
ously at a young age after severe bradycardia, which has been 
interpreted as indicating that these mice die from intrinsic car-
diac dysfunction (7). However, selective knockout of Scn1a only 
in brain interneurons results in seizures and spontaneous death 
(43). In mice with global knockout of Scn1a, heat-induced sei-
zures are associated with progressively worsening bradycardia 
followed by terminal asystole (40). Bradycardia and death can 
be prevented by pretreatment with atropine (40). These data led 
to a different conclusion — that death in this DS mouse model 
Table 1. Patients with DS had abnormal breathing after seizures 
compared with patients with localization-related epilepsy  
(P = 0.018, χ2 test)
Patients with  
DS
Patients with  
localization-related epilepsy
Respiratory rhythm disturbance
 Yes 4 0
 No 3 7
Loud postictal upper airway soundsA
 Yes 1 3
 No 6 4
ANoisy expiration, stertor, and grunting.
Figure 1. Seizures induce ataxic breathing in a patient with DS. (A and B) Irregular breathing during and after a seizure. Video frame (A) from Supple-
mental Video 1 showing region of interest (vertical line pointed to by arrow) used to visualize respiratory movements. Using the methods illustrated in 
Supplemental Figure 1A, respiratory movements were plotted during and after a generalized seizure (B; traces are contiguous). During the seizure (first 13 
seconds), most inspirations had more than one peak. Immediately after the seizure, there was a respiratory pause followed by continued abnormal inspi-
rations lasting until 32 seconds postictal. A normal breathing pattern then resumed with regular, monophasic inspiratory efforts.
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baseline. During most of the time after the seizures, the patient 
continued breathing at a rate of 18–22 breaths per minute without 
apnea (Figure 2E). However, the elevated tcCO2 indicated there 
was marked hypoventilation, apparently due to decreased tidal vol-
ume. It is not clear whether diazepam contributed to the hypoven-
tilation. This case was remarkable for impairment of respiratory 
CO2 chemoreception that continued long after the seizure. It also 
demonstrated that supplementary oxygen is not adequate treat-
ment when the primary problem is hypoventilation. Three years 
after the patient was recorded, she was found face down in bed, 
blue and pulseless, and could not be resuscitated. An autopsy was 
performed and the cause of death was given as SUDEP.
Taken together, these data indicate that many patients with 
DS have peri-ictal respiratory dysfunction that can extend long 
into the postictal period, including defects in respiratory rhythm 
generation, impaired central CO2 chemoreception, and loss of 
airway patency. In the nonfatal episodes documented here, these 
changes were transient, but the severe defects in breathing in the 
patient who later died of SUDEP suggest that respiratory changes 
may be biomarkers of patients at high risk.
Spontaneous seizures caused death in Scn1aR1407X/+ mice due to 
respiratory arrest. Heterozygous Scn1aR1407X/+ knockin mice that 
express a mutation described in 3 unrelated patients with DS were 
secutive generalized tonic-clonic seizures. The seizures on EEG 
lasted 48 seconds, 89 seconds, and 90 seconds, separated by 1–3 
minutes (Figure 2A). Rectal diazepam (0.5 mg/kg) was given 
during the second seizure. Between seizures the patient’s eyes 
were open, but she had a limited response to verbal and tactile 
stimuli, and the EEG showed continuous slowing with frequent 
interictal epileptiform discharges. Epileptiform discharges and 
EEG slowing decreased after the third seizure.
Before the first seizure, plethysmography revealed normal, 
regular breathing (Figure 2B), and tcCO2 was 43–44 mmHg. Dur-
ing and after the seizures, the patient developed labored breathing 
with periods of apnea lasting up to 13 seconds (Figure 2, C–E). After 
the first seizure, oxygen desaturation occurred and the patient was 
treated with O2 delivered by a nonrebreather mask at an initial rate 
of 15 LPM and subsequently adjusted to keep O2 saturation greater 
than 92%. O2 was removed after the third seizure. tcCO2 increased 
during the seizures to 53–55 mmHg. Approximately 45 minutes 
after the third seizure, the patient developed labored breathing. 
Oxygen desaturation occurred and O2 was given again. At the time, 
tcCO2 had increased to 68 mmHg and remained at 70 mmHg for 
the next hour. At 2 hours, a painful stimulus was given that caused 
the patient to arouse, and tcCO2 declined to just above 50 mmHg 
where it remained for an additional 2 hours before returning to 
Figure 2. Prolonged postictal hypoventilation in a patient with DS. (A) Schematic of events while recording cardiorespiratory activity during and after a 
seizure in a 9-year-old girl with DS. The numbers above the upper line in A are measured values of tcCO2. The upper line shows the approximate time course 
of the changes in tcCO2. Arrows labeled “b-e” denote the time of recordings shown in parts B–E, respectively. Arrows also denote when supplemental O2 was 
administered or discontinued, and when the patient was stimulated to cause arousal. Red shading denotes convulsive seizures and orange shading denotes 
periods of decreased responsiveness and EEG slowing. (B–E) Respiratory impedance plethysmography (Pleth) and ECG during normal breathing when tcCO2 
was 43 mmHg (B), between convulsive seizures (C), after the seizures when tcCO2 had risen to 53 mmHg (D), and 44 minutes after the seizures when tcCO2 
had risen to 68 mmHg (E). At 2 hours, tcCO2 decreased when the patient was stimulated to arouse, but did not return to baseline until 4 hours.
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or was accompanied by apnea. During our experiments, we mea-
sured the EEG and breathing, along with the ECG, so we were able 
to evaluate whether spontaneous episodes of bradycardia were 
due to seizures or apnea. During a total of 441 hours monitoring 
EEG, ECG, and plethysmography from the 2 mice that died spon-
taneously, one had 3 spontaneous nonfatal seizures and the other 
had 4. All 7 of these seizures were generalized with clonic limb 
contractions and were classified as Racine scale 5 seizures. Three 
of these nonfatal seizures included transient episodes of apnea 
and bradycardia that were less severe than during fatal seizures 
(Supplemental Figure 5). Bradycardia never occurred without 
apnea or severely decreased breath amplitude.
Heat-induced seizures also caused respiratory arrest in Scn1aR1407X/+ 
mice. As in patients with DS (31), an increase in body temperature 
can induce seizures in Scn1aR1407X/+ mice (45) and Scn1a-knockout 
mice (40). It has been reported that heat-induced seizures in DS 
mice lead to bradycardia followed by death (40). Here we verified 
that a rise in body temperature induced seizures in Scn1aR1407X/+ 
mice, with the first seizure occurring at an average of 39.67°C ± 
0.97°C (n = 21) and leading to death in 18 of 21 mice after 3.53 ± 0.68 
seizures. As reported previously with fatal heat-induced seizures in 
Scn1a-knockout mice (40), electrographic seizures accompanied 
by tonic hind limb extension or clonic limb contractions were fol-
lowed by a decrease in heart rate that eventually resulted in termi-
nal asystole (Supplemental Figure 6). However, we found that fatal 
seizures also always involved terminal apnea. This apnea occurred 
precipitously during the seizure or within seconds of the end of the 
seizure. In contrast, mild to moderate bradycardia often occurred 
shortly after the onset of apnea, but a heartbeat continued, slowly 
decreasing over time with terminal asystole not occurring until 3.89 
± 0.92 minutes after the end of seizures. Death could be prevented 
if mechanical ventilation was initiated within 5–10 seconds of the 
onset of apnea using a rodent ventilator (MiniVent type 845; Har-
vard Apparatus) connected to plastic tubing placed over the mouse’s 
nostrils (n = 5 mice). Death in this group of mice always occurred 
due to apnea, and bradycardia only occurred if there was apnea.
MES also induced generalized seizures in Scn1aR1407X/+ mice, 
but these seizures were less likely to cause apnea (4 episodes of 
apnea after seizures in 34 mice). When apnea did occur, death was 
prevented by mechanical ventilation in 3 of 4 mice.
High-dose atropine prevented peri-ictal apnea in Scn1aR1407X/+ mice. 
It has previously been shown that atropine prevents postictal bra-
dycardia and death in Scn1a-knockout mice after hyperthermia-
induced seizures (40). This led to the conclusion that seizures cause 
fatal bradycardia due to an increase in vagal parasympathetic out-
put and activation of cardiac muscarinic acetylcholine receptors 
(40). To examine the mechanism by which atropine prevents post-
ictal death, we induced seizures in Scn1aR1407X/+ mice using hyper-
thermia 30 minutes after pretreatment with 1 mg/kg (i.p.) atropine 
and compared the seizures to a matched cohort of Scn1aR1407X/+ mice. 
Atropine (1 mg/kg) did not reduce the likelihood of Racine scale 5 
seizures, or the duration or severity of seizures as determined by 
EEG analysis (see Methods), but did reduce the likelihood of tonic 
hind limb extension. Death occurred in only 2 of 9 mice treated with 
atropine (1 mg/kg) compared with 6 of 6 mice treated with vehicle 
(Figure 5A). Unexpectedly, atropine (1 mg/kg) also prevented apnea 
in all mice that survived (n = 7 of 9) (Figure 5B). For mice treated with 
used to define the cause of death after seizures (39). Video record-
ings were made continuously of 78 Scn1aR1407X/+ mice between the 
ages of P16 and P60. During that time, 38% of the mice sponta-
neously died (n = 30 of 78) (Figure 3). There was no difference in 
mortality between male and female mice (Supplemental Figure 
3). Review of the video recordings revealed that all spontaneous 
deaths occurred after a generalized seizure characterized by ton-
ic hind limb extension. All spontaneous seizures with tonic hind 
limb extension were fatal.
To better understand the cause of postictal death in 
Scn1aR1407X/+ mice than is possible using video recording alone, a 
custom-designed mouse EMU was used to continuously monitor 
EEG, ECG, electromyography (EMG), video, and plethysmogra-
phy. In 4,680 hours of recording from 19 Scn1aR1407X/+ mice, 2 mice 
died from spontaneous seizures. One mouse that was monitored 
for 408 hours from P23 to P40 (Figure 4) died after a seizure with 
tonic hind limb extension. Breathing and heart rate were both nor-
mal prior to the seizure. During the seizure, the mouse suddenly 
developed complete apnea that continued into the postictal period, 
and it never recovered. There was also a rapid decrease in heart 
rate shortly after the onset of apnea, but the heartbeat remained 
above 25%–51% of control for 60 seconds after the onset of apnea 
and continued for almost 4 minutes after the end of the seizure, 
with slowly worsening bradycardia eventually leading to terminal 
asystole. A similar sequence of events was seen in a second mouse 
monitored for 33 hours starting at P23 (Supplemental Figure 4). 
These observations suggest that respiratory arrest played a key role 
in the death of these animals. For both mice, recordings revealed 
central apnea, as there was no evidence for airway obstruction in 
the video recording, EMG, or plethysmography trace. Notably, the 
EEG rapidly became flat after the seizure, consistent with PGES 
(25). This same observation was reported previously after maximal 
electroshock (MES) induced seizures in Lmx1bf/f/p mice, which lack 
over 99% of 5-hydroxytryptamine (5-HT) neurons in the CNS (19).
Auerbach et al. (7) reported episodes of bradycardia and 
increased HRV in Scn1aR1407X/+ mice up to 48 hours prior to death. 
They did not measure breathing or EEG during those episodes, so 
it is not known whether the bradycardia occurred during seizures 
Figure 3. Survival curve of Scn1aR1407X/+ mice. Video monitoring revealed 
that 38% (n = 30 of 78) of Scn1aR1407X/+ mice spontaneously died between 
P20 and P60. All of these spontaneous deaths occurred after Racine scale 
5 generalized seizures with tonic hind limb extension.
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Quaternary ammonium derivatives of muscarinic receptor 
antagonists, such as methylatropine and N-methylscopolamine, 
are used as selective antagonists of peripheral muscarinic recep-
tors, as they are less likely to penetrate the blood-brain barrier 
(56, 57). N-methylscopolamine (1 mg/kg, i.p.) has previously 
been shown to prevent bradycardia and death after heat-induced 
seizures in Scn1a-knockout mice, supporting the hypothesis that 
postictal bradycardia is due to an increase in vagal tone (40). We 
replicated this experiment in Scn1aR1407X/+ mice (n = 6), but found 
that pretreatment with N-methylscopolamine (1 mg/kg, i.p.) 30 
minutes prior to inducing seizures with hyperthermia did not 
prevent apnea, bradycardia, or death (Figure 5A). In contrast, 
methylatropine (1 mg/kg, i.p.) (n = 6) did prevent bradycardia 
and death (Figure 5A), but also prevented apnea. Selective block-
ade of peripheral muscarinic receptors would not be expected to 
atropine that died (n = 2 of 9), the sequence of events was identical 
to that of mice treated with vehicle, with immediate and complete 
apnea beginning near the end of a generalized seizure, followed by 
slowly progressive bradycardia.
It is common to use atropine at a dose of 1 mg/kg to block periph-
eral muscarinic receptors in rodents. However, that dose is 20–50 
times higher than is recommended for specific blockade of periph-
eral muscarinic receptors in mice (0.02–0.05 mg/kg, i.p.) (46–48). 
Atropine can readily cross the blood-brain barrier (49, 50). After 30 
minutes, levels of atropine in the CNS reach more than 35% of serum 
levels (49). After a dose of 1 mg/kg, atropine levels would be more 
than enough to block central muscarinic receptors. Muscarinic ace-
tylcholine receptors in the medulla and pons play an important role 
in respiratory control (51, 52) and central CO2 chemoreception (53, 
54), and those receptors in the forebrain alter seizure activity (55).
Figure 4. Death of an Scn1aR1407X/+ mouse 
(P40) after a spontaneous seizure 
was due to respiratory arrest followed 
by secondary bradycardia. (A) Events 
leading to death. Traces from top down 
are EEG, ECG, EMG, and whole-animal 
plethysmography (Pleth), in each case 
with paired power spectrum heatmaps. 
A spontaneous seizure occurred at the 
time indicated, and this was followed 
by PGES in the EEG. Shortly after the 
onset of the seizure, breathing became 
disrupted. Respiratory activity ceased 
halfway through the seizure. In contrast, 
the ECG did not change until near the 
end of the seizure, after which the fre-
quency and amplitude slowly decreased 
over the next 4 minutes. Note there 
was some movement artifact on the 
plethysmography trace half way through 
the seizure. (B) Expanded traces of 
EEG, ECG, and plethysmography at the 
times labeled 1–5. (C) Respiratory rate 
and heart rate for the data shown in A 
and B. Data are discontinuous during 
the baseline period, because accurate 
measurements could be made only when 
the mouse was resting quietly. Data 
points are continuous from the onset of 
the seizure, except for one data point 
during which breathing was obscured by 
movement artifact.
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prevent apnea, because the neural circuitry involved in genera-
tion of respiratory output is contained entirely within the CNS, as 
are descending projections from the forebrain that cause apnea 
during and/or after seizures (18, 20). Instead, the effect of meth-
ylatropine is likely to be due to penetration into the CNS. After 
equivalent doses of radioactive atropine or methylatropine, both 
drugs accumulate in the CNS (58). Systemic methylatropine has 
effects on cortical activity that are dependent on the dose and 
treatment duration, with 1 mg/kg (i.v.) inhibiting EEG activity by 
70% within 20–30 minutes (59). Our data also indicate that high 
doses of quaternary ammonium anticholinergic agents can have 
central effects, and these high doses are protective against apnea.
Selective blockade of peripheral muscarinic receptors does not pre-
vent postictal bradycardia. An atropine dose of 0.02–0.04 mg/kg 
(i.p.) is recommended to block peripheral parasympathetic activity 
in mice (46–48). Measurement of HRV can be used to determine 
whether muscarinic receptor antagonists are effective at blocking 
vagal parasympathetic output to the heart. The most common type 
of HRV, respiratory sinus arrhythmia, is due to changes in para-
sympathetic output caused by breathing (60–64). This results in 
part from an increase in intrathoracic pressure during expiration, 
which leads to an increase in systemic blood pressure and reflex 
bradycardia (and opposite changes during inspiration). Blocking 
parasympathetic output eliminates this form of HRV (60–64). 
To verify that muscarinic receptor antagonists were effective in 
blocking peripheral muscarinic receptors, Poincaré plots (65) were 
used to analyze variability of the R-R interval on the ECG (Figure 
6). Compared with WT mice, Scn1aR1407X/+ mice had significantly 
greater long-term (SD2) HRV (Figure 6, A and B, and Supplemen-
tal Figure 7, C and D). Atropine reduced SD2 in Scn1aR1407X/+ mice 
and was equally effective at 1 mg/kg and 0.03 mg/kg (Figure 6, C 
and D, and Supplemental Figure 7, C and D). Despite the ability of 
the lower dose of atropine to block peripheral muscarinic recep-
tors, all Scn1aR1407X/+ mice in which seizures with tonic hind limb 
extension were induced by hyperthermia after pretreatment with 
0.03 mg/kg atropine still developed bradycardia and died (Figure 
5A; n = 6 of 6), but they also developed apnea (data not shown). 
N-methylscopolamine (1 mg/kg; n = 6) and methylatropine (1 mg/
kg; n = 6) both caused a decrease in short-term (SD1) and long-term 
HRV (SD2) (Supplemental Figure 7). Despite the ability of all of 
these treatments to block vagal parasympathetic output, only some 
prevented postictal bradycardia and death. Those treatments that 
were protective prevented peri-ictal apnea, and those that were not 
protective did not prevent apnea.
Selective blockade of central muscarinic receptors prevented peri-
ictal apnea and bradycardia. Scn1aR1407X/+ mice (n = 5) were treated 
with i.c.v. N-methylscopolamine at a dose of only 0.3 μg/kg. This 
agent was the least permeable across the blood-brain barrier (see 
above), so it should have remained restricted to the CNS. However, 
even if the drug freely crossed the blood-brain barrier and was dis-
tributed throughout the body, this dose would still be only 1% of that 
required to block peripheral muscarinic receptors (0.03 mg/kg) and 
thus would not reach levels high enough to block parasympathetic 
drive to the heart. Thirty minutes after i.c.v. injection of N-meth-
ylscopolamine (0.3 μg/kg), hyperthermia was induced to at least 
42.5°C, resulting in an average of 3.33 ± 0.89 seizures per mouse. 
Figure 5. Postictal bradycardia is due to apnea, not increased para-
sympathetic drive. (A) Effect of muscarinic antagonists on postictal 
heart rate after heat-induced seizures (HISs). Untreated mice all died in 
response to HIS (n = 6). Atropine prevented bradycardia in 7 of 9 mice 
when given at a dose of 1 mg/kg (i.p.). Methylatropine (1 mg/kg, i.p.) 
also prevented bradycardia in 6 of 6 mice. Treatment with N-meth-
ylscopolamine at very low dose (0.3 μg/kg, i.c.v.) prevented bradycardia 
in all mice (n = 5). In contrast, atropine (1 mg/kg, i.p.) did not prevent 
bradycardia or death in 2 of 9 mice, or when given at 0.03 mg/kg (n = 6 
of 6; i.p.), a dose selective for blockade of peripheral muscarinic recep-
tors. Bradycardia also occurred after spontaneous seizures (n = 2) and 
after pretreatment with N-methylscopolamine (1 mg/kg, i.p.; n = 6 of 6). 
All mice with postictal bradycardia also had apnea, whereas bradycardia 
did not occur in any mouse without apnea. T = 0 represents the time 
that apnea began (always during or at the end of seizures) or the end 
of seizures (if apnea did not occur). Error bars are not shown for the 2 
groups with n = 2. (B) Heat-induced seizure in an Scn1aR1407X/+ mouse, 
30 minutes after pretreatment with atropine (1 mg/kg, i.p.). During this 
seizure, there was no apnea or bradycardia, and the mouse did not die.
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Generalized seizures were induced in 5 of 5 mice at a body tempera-
ture of 40.7°C ± 0.53°C. All of the Scn1aR1407X/+ mice had generalized 
seizures with tonic hind limb extension or clonic limb contractions 
(n = 5), but none developed apnea or bradycardia, or died (Figure 7, 
A and B). Poincaré plots were used to evaluate ECG changes. There 
was no change in mean heart rate or HRV after i.c.v. N-methylsco-
polamine (0.3 μg/kg) (Figure 7C). Thus, i.c.v. N-methylscopolamine 
had no effect on peripheral muscarinic receptors, but prevented 
bradycardia by blocking apnea via an effect in the CNS.
Hypoxia caused bradycardia due to a direct effect on the heart. 
Based on the above results, we hypothesized that seizures caused 
apnea, and the resulting hypoxia had a direct negative chronotropic 
effect on cardiac tissue. Consistent with this possibility, during vas-
cular perfusion of the isolated rat heart ex vivo, it has been shown 
that hypoxia causes a decrease in heart rate and cardiac contractility 
due to a direct effect on the heart (66). WT (n = 5) and Scn1aR1407X/+ 
(n = 6) mice were anesthetized with isoflurane (1%) and placed in 
a whole-body plethysmograph. After recording baseline ECG and 
breathing, ambient gas was switched from normoxia (21% O2 / 79% 
N2) to anoxia (0% O2 / 100% N2). This led to bradycardia with a 
time course similar to that seen after seizures in Scn1aR1407X/+ mice 
(Figure 8). It also caused a decrease in amplitude of the QRS com-
plex, as also occurred after fatal seizures, presumably a surrogate of 
decreased cardiac contractility (66). Pretreatment of WT mice with 
atropine at 1 mg/kg (n = 5) did not prevent the bradycardia induced 
by anoxia (Figure 8), indicating that the decrease in heart rate was 
not mediated by an increase in vagal output.
Discussion
Here we show that patients with DS have peri-ictal breathing 
dysfunction, including ataxic respiratory output, paradoxical 
breathing, airway obstruction, and prolonged depression of CO2 
chemoreception that lasted as long as 4 hours after the end of 
seizures. The respiratory abnormalities we recorded were tran-
sient. However, a child with particularly severe and prolonged 
postictal hypoventilation later died of SUDEP. These results sug-
gest that postictal ventilatory abnormalities may play a major 
role in SUDEP in patients with DS and may be a biomarker for 
those at highest risk.
We also studied seizures in a DS mouse model and found that 
postictal death was due to immediate fatal apnea. In contrast, Kal-
ume et al. (40) reported that postictal death after heat-induced sei-
zures in Scn1a-knockout mice is due to severe bradycardia and this 
was proposed to be due to increased vagal parasympathetic tone. 
This conclusion was supported by data showing that death was pre-
vented by treatment with atropine (40). Auerbach et al. (7) report-
ed spontaneous death preceded by bradycardia in 3 Scn1aR1407X/+ 
mice, and in that study, death was attributed to abnormal intrinsic 
electrophysiological properties of cardiac myocytes (7). However, 
breathing was not measured in either the study by Auerbach et 
al. (7) or the study by Kalume et al. (40). Here we report postictal 
bradycardia in Scn1aR1407X/+ mice with a similar time course to that 
previously reported (7, 40), but found that central apnea occurred 
prior to bradycardia. Apnea rapidly causes hypoxemia in mice and 
rats within seconds (67, 68). Therefore, the long duration of apnea 
we saw in response to seizures would be expected to cause a severe 
drop in blood oxygen. Hypoxemia has a negative chronotropic 
effect on the heart (66), explaining why atropine did not prevent 
bradycardia in response to exposure to hypoxic gas (Figure 8).
We found that atropine was protective against peri-ictal bra-
dycardia, but this was not due to blockade of parasympathetic 
output. Instead, at high doses, atropine prevented peri-ictal apnea 
due to a central effect. Peri-ictal apnea and bradycardia were not 
prevented by selective blockade of peripheral muscarinic recep-
tors using atropine at a low dose (0.03 mg/kg, i.p.) or the relatively 
membrane-impermeable N-methylscopolamine at a high dose 
(1 mg/kg, i.p.). In both cases, blockade of peripheral muscarinic 
receptors was verified by suppression of HRV. In contrast, peri-
ictal apnea and bradycardia were both prevented by selective 
blockade of central muscarinic receptors using a very low dose 
of N-methylscopolamine (0.3 μg/kg, i.c.v.). Mice were protected 
from death even though peripheral muscarinic receptors were not 
blocked, as verified by a lack of effect on HRV. These results indi-
cate that muscarinic receptor antagonists prevent postictal death 
by blocking central apnea rather than blocking vagal output.
Our results with systemic N-methylscopolamine were differ-
ent from those of Kalume et al. (40), who found protection from 
death despite using the same concentration and route of delivery. 
Figure 6. Low-dose and high-dose atropine were equally effective at 
blocking HRV. (A and B) Poincaré plots demonstrated greater short-term 
and long-term HRV (SD1 and SD2, respectively) in an Scn1aR1407X/+ mouse 
compared with a WT mouse. (C) High-dose atropine (1 mg/kg) reduced 
HRV in an Scn1aR1407X/+ mouse, consistent with blockade of parasympa-
thetic output. (D) Low-dose atropine (0.03 mg/kg) was equally effective 
in reducing HRV in an Scn1aR1407X/+ mouse. The plots in the 4 parts of this 
figure are from 4 individual animals. Summary data for replicate animals 
for these experiments are shown in Supplemental Figure 7. Number of 
replicates for each group was 7 (A), 10 (B), 6 (C), and 6 (D).
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an effect on the respiratory network. Muscarinic receptors in the 
medulla play an important role in respiratory control (51, 52) and 
central respiratory CO2 chemoreception (53, 54). Depending on 
the site of action, muscarinic receptor activation can either stimu-
late or inhibit breathing (51, 52, 54, 69, 70). Acetylcholinesterase 
inhibitors block central respiratory rhythm generation via an effect 
in the brain stem (69, 71), and this central apnea can be prevented 
by atropine (72). It is possible that similar muscarinic mechanisms 
contribute to peri-ictal apnea in Scn1aR1407X/+ mice. It is also pos-
sible that muscarinic receptors in the forebrain alter seizures (55) 
so they are less likely to cause apnea. Defining the specific mecha-
nisms of apnea that are blocked by atropine analogues may help to 
identify methods for prevention of SUDEP.
There are many open questions about the mechanisms of 
death in DS mice. For example, it is not clear whether Scn1a 
mutations increase the likelihood of invasion of the brain stem 
by seizures or make the respiratory network more likely to fail in 
response to descending input. It is not known which neurons in the 
brain stem express Scn1a and whether those neurons are involved 
in breathing. Seizures and death can be prevented in heterozygous 
Scn1a-knockout mice with GS967, a drug that inhibits persistent 
sodium current (73), but it is not clear whether persistent sodium 
current plays a role in peri-ictal apnea.
The reason for this difference is unclear, but it is possible that 
the drug was able to penetrate into the CNS more easily in their 
study, perhaps because the blood-brain barrier was leakier due to 
a larger number of seizures. There may also be strain differences 
in sensitivity to the drug. Although relatively membrane imper-
meable, N-methylscopolamine can still cross the blood-brain 
barrier. However, given its equipotency with atropine, systemic 
N-methylscopolamine should be able to block peripheral mus-
carinic receptors at a dose of only 0.02–0.04 mg/kg. If its target 
was peripheral receptors, a systemic dose of 1 mg/kg should not 
be necessary. When delivered directly into the lateral ventricle, a 
3,000-fold lower dose of only 0.3 μg/kg was sufficient to protect 
from seizure-induced death, supporting the hypothesis that the 
pharmacological target is in the brain.
These results indicate that atropine analogues have effects in 
the CNS that prevent seizure-induced apnea. High-dose systemic 
atropine did not reduce the duration or severity of heat-induced 
seizures as determined by EEG analysis or decrease the likelihood 
of Racine scale 5 seizures, but it did decrease the likelihood of ton-
ic hind limb extension, suggesting there were effects on forebrain 
seizure activity. It is not known whether an effect on seizures in 
the forebrain protected against apnea or whether protection was 
due to inhibition of forebrain projections to the brain stem or to 
Figure 7. Peri-ictal apnea, bradycardia, and death were prevented by N-methylscopolamine administered into the lateral cerebral ventricle at very low 
dose (0.0003 mg/kg). (A) Heart rate and breathing did not change in response to a heat-induced Racine scale 5 seizure in an Scn1aR1407X/+ mouse. A seizure 
occurred at the time indicated. Insets to the right were obtained at the times indicated with the vertical lines on the left. Respiratory activity and the ECG 
did not change during the seizure. Note that there was movement artifact seen intermittently on the respiratory trace. Sudden changes in amplitude of 
the ECG were also an artifact due to movements of the animal. (B) Summary of results from Scn1aR1407X/+ mice with heat-induced Racine scale 5 seizures 
after N-methylscopolamine (0.3 μg/kg, i.c.v.; n = 5). Breathing and heart rate were not affected in any of the mice. (C) Poincaré plots demonstrated that 
N-methylscopolamine (0.3 μg/kg, i.c.v.) did not block peripheral muscarinic receptors as seen by the lack of an effect on R-R interval. The Poincaré plots 
shown here are from a single animal. Summary data for replicate animals for this experiment are shown in Supplemental Figure 7. Number of replicates 
was 4 animals.
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shared with those in other types of epilepsy. However, the results 
presented here may also be relevant to SUDEP in other types of 
epilepsy, since peri-ictal apnea has previously been reported as 
the cause of death in Lmx1bf/f/p, DBA, and 5-HT2c knockout mice 
(19, 21, 76). For a seizure to induce apnea, forebrain activity must 
propagate to the lower brain stem where breathing is controlled. 
The likelihood for this may vary depending on the type of seizure, 
whether the relevant descending projections are engaged, and how 
sensitive the respiratory network is to descending input.
Cardiac abnormalities clearly play an important role in many 
cases of SUDEP, likely including some cases of DS, but it can be 
misleading to focus attention on cardiac changes without simul-
taneously evaluating breathing and blood gases, since changes in 
O2, CO2, and pH can induce a variety of cardiovascular abnormali-
ties, including bradycardia and tachyarrhythmias. This is of prac-
tical clinical importance, since a cardiac pacemaker would not be 
appropriate for preventing SUDEP in a patient with bradycardia 
secondary to central apnea. Instead, interventions that restore ven-
tilation would be more logical for rescuing patients with epilepsy 
who have peri-ictal respiratory arrest. Patients with epilepsy at high 
risk of apnea would be prudent to avoid alcohol and medications 
that depress breathing. Stimulating arousal to reinitiate breathing 
or use of ventilatory assistance with a bag valve mask or mouth-to-
mouth resuscitation may be more effective than cardiac interven-
tions, as they would reverse a primary defect of hypoventilation.
Methods
Monitoring of patients with DS with video EEG telemetry. Patients were 
admitted to the pediatric EMU at Lurie Children’s Hospital (Chicago, 
Illinois, USA) for routine video-EEG monitoring of refractory seizures. 
Seven patients with DS and convulsive seizures were selected for video 
analysis along with 7 patients with convulsive seizures from localiza-
tion-related epilepsy. Respiratory movements were difficult to visual-
ize in some video recordings. Therefore, visualization of movements 
was enhanced using phase-based Eulerian video magnification motion 
processing (44) with open-source software (http://people.csail.mit.edu/
mrub/vidmag/) written for MATLAB (Mathworks Co.). Video motion 
magnification processing was performed on video recordings with 
amplification of ×4 or ×10, applying a bandpass filter of 0.05–3.0 Hz.
To better visualize breathing in video images, a vertical line was 
drawn through a part of the body that showed large movements (the 
umbilicus in Figure 1A and Supplemental Figure 1A). Using a custom-writ-
ten MATLAB script, the color value was determined at each point along 
the vertical line for each video frame. These values were used to create a 
graph with time (T; consecutive video frames) represented on the x axis, 
vertical location on the y axis (Y), and color in relative units on the z axis 
(Supplemental Figure 1B). The breathing trace in this spatiotemporal YT 
slice was rendered more apparent by converting the image to grayscale 
and enhancing the contrast. The most visible single breathing trace was 
The relationship among BSD (24), PGES (25), and peri-ictal 
apnea remains unclear. It is not known whether BSD occurs in our 
model. PGES always occurred in Scn1aR1407X/+ mice that died, as 
was previously reported in Lmx1bf/f/p mice after MES seizures (19). 
BSD, PGES, and apnea could all be reflective of some underlying 
causative mechanism. One may cause the other 2, or they could 
be independent processes. It does not appear that PGES caused 
apnea, since apnea often occurred before PGES (Figure 4) and 
because generation of the automatic respiratory rhythm in the 
brain stem does not require descending input from the forebrain. 
Further work is required to define the sequence of these and other 
ictal and postictal events. What is clear is that when seizures are 
fatal, the apnea is immediate and severe. There is even com-
plete suppression of gasping, or “autoresuscitation,” which usu-
ally occurs as a terminal event and is induced by severe hypoxia, 
indicating that there is such profound inhibition of the brain stem 
respiratory network that gasping does not even occur.
We observed that Scn1aR1407X/+ mice had greater HRV than WT 
mice, whereas Kalume et al. (40) observed that Scn1a-knockout 
mice had less HRV than WT mice. This difference is likely to be 
methodological, as our measurements of HRV were designed for 
a different purpose than those of Kalume et al. (40). In our study 
we examined the R-R interval over a short time period (30–40 sec-
onds) when mice were lying in their cage motionless but awake, 
whereas Kalume et al. (40) examined the R-R interval over a long 
period (8 hours) during a variety of normal behaviors and activity 
levels. There are differences in HRV under different levels of ani-
mal activity (63). We chose to use the former method, as our goal 
was to verify block of peripheral muscarinic receptors. Kalume et 
al. (40) measured HRV over a long period to test the hypothesis 
that decreased HRV is a risk factor for SUDEP. The existing evi-
dence does not yet support the latter hypothesis (74), although a 
decrease in HRV has been linked to a high risk of sudden cardiac 
death in humans (75). There is no evidence that the increase in 
HRV for short periods reported here in DS mice confers a higher 
risk of SUDEP, nor was that the purpose of these measurements.
It is not known how commonly death in other mouse models of 
SUDEP is due to the mechanisms described here. Similarly, it is not 
known whether the mechanisms of SUDEP in patients with DS are 
Figure 8. Anoxia caused bradycardia due to a direct effect on the heart. 
WT mice exposed to anoxia developed bradycardia (n = 5). Pretreatment 
with atropine (1 mg/kg, i.p.) caused an increase in baseline heart rate, but 
did not prevent this bradycardia (n = 5), indicating that bradycardia was 
not due to increased vagal output. Scn1aR1407X/+ mice also developed brady-
cardia in response to anoxia (n = 6).
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flow of room air at approximately 400 ml/min via supply and exhaust 
air pumps (MK-1504 Aquarium Air Pump; AQUA Culture) balanced 
to maintain chamber pressure near atmospheric. Mice had access to a 
continuous supply of water and food.
The EMU/plethysmography chamber pressure was measured 
using a digital differential pressure transducer (SDP610-25Pa; Sensi-
rion AG). Chamber temperature and relative humidity were also 
continuously monitored (HIH-6130 sensor; Honeywell International 
Inc.). Signal outputs from the pressure transducer and temperature/
humidity sensor were connected to a microcontroller (Teensy 3.1; 
PJRC.com) using a custom-designed printed circuit board. The digi-
tal transducers and microcontroller communicated through an inter-
integrated circuit (I2C) interface via the Arduino platform (ARDUINO 
1.6.9; Arduino.cc, and Teensyduino 1.28; PJRC.com) to upload con-
figuration code of the digital sensors to the microcontroller board. 
Chamber temperature, relative humidity, and pressure were acquired 
continuously at 100 Hz through a USB port with data acquisition soft-
ware custom written in MATLAB. Breathing caused changes in pres-
sure in the chamber due to heating and humidification of inspired air 
based on well-established physical principles, and these were used to 
calculate changes in lung volume (79).
EEG, EMG, and ECG leads were tethered to a commutator (cat-
alog 8408; Pinnacle Technology Inc.) and connected to an ampli-
fier (Model 440 Instrumentation Amplifier; Brownlee Precision 
Co.) where signals were amplified ×10 and bandpass filtered (EEG, 
0.3–400 Hz; EMG, 10–500 Hz; ECG, 1–500 Hz). These signals were 
digitized with an analog-to-digital converter (PCI-6225; National 
Instruments Corp.) in a desktop computer and acquired with the same 
custom-written MATLAB data acquisition software. Body tempera-
ture and activity were captured by a telemetry receiver (ER-4000, 
Energizer Receiver; Mini-Mitter, Inc.) placed beneath the recording 
chamber, transmitted to the computer via a serial port, and sampled 
every 10 seconds with the same custom-written MATLAB data acqui-
sition software. All digitized data were saved on external hard drives.
Monitoring of spontaneous deaths in mice. One cohort of Scn1aR1407X/+ 
mice (n = 78) was monitored for spontaneous deaths using video 
recording only (Figure 3). Uninstrumented mice were housed in their 
home cages and continuous video monitoring was performed from 
P16–P60. Video recordings were made at 30 frames per second using 
a night vision web camera (FL8910W; Foscam Digital Technologies). 
Up to 32 cameras were connected to a single computer, and video 
recordings were stored on an external hard drive using commercial 
video webcam software (Blue Iris 4; Foscam Digital Technologies). 
When a mouse was found dead in a cage, the video was reviewed to 
determine the time of death and whether death was preceded by a 
behavioral seizure.
A second cohort of Scn1aR1407X/+ mice (n = 19) was monitored for 
spontaneous deaths over 195 days using video recording as well as EEG, 
EMG, ECG, and measurements of breathing, temperature, and activity. 
Each recording session lasted up to 24 hours, after which the EMU was 
opened and cleaned. Mice were then returned to the EMU for contin-
ued monitoring or to their home cage. While in the EMU, mice had free 
access to food and water. Long-term mouse EMU data were continu-
ously stored on an external hard drive (DRDR5A21-20TB; DroboWorks.
com). In 4,223 total hours of recording 19 mice between P23 and P40, 2 
mice died spontaneously. When these mice died, monitoring was termi-
nated and data were reviewed to assess cause of death.
selected by cropping the spatiotemporal YT image (Supplemental Figure 
1, C and D) and drawing a line along the center of the trace (Supplemental 
Figure 1E) using image editing software (Corel PhotoPaint).
In a single patient (Figure 2), measurements of breathing were 
made using respiratory impedance plethysmography (Piezo Crystal 
Respiration Effort Sensors, SleepSense), tcCO2, SaO2 (SenTec Digital 
Monitoring System, SenTec AG), ECG, and video EEG.
Mouse husbandry and genotyping. A pair of Scn1aR1407X/+ hetero-
zygous male mice on a C3HFeB/HeJ background were provided 
by Miriam Meisler (University of Michigan, Ann Arbor, Michigan, 
USA), and were bred with C3HFeB/HeJ female mice (Jackson Labo-
ratory) to establish a breeding colony. Breeding and genotyping of 
these mice have been previously described (7). Briefly, DS mice were 
genotyped by PCR amplification with the primers DS-F (5′ CAAT-
GATTCCTAGGGGGATGTC 3′) and DS-R (5′ GTTCTGTGCACT-
TATCTGGATTCAC 3′). Digestion of the PCR product with HpaII 
generated 2 fragments (295 bp and 223 bp) from the WT allele and an 
uncut fragment (518 bp) from the mutant allele. Genomic DNA was 
PCR amplified, digested with HpaII, and separated on 2% agarose gels 
containing 0.15 μg/ml ethidium bromide.
EEG/EMG/ECG headmount and activity/temperature telemetry 
implants. EEG/EMG/ECG custom headmounts (8400-K1; Pinnacle 
Technology Inc.) were implanted in P16–P22 DS mice as previously 
described (77). Briefly, mice received preoperative analgesia (meloxi-
cam, 0.5 mg/kg, i.p.; or buprenorphine, 0.1 mg/kg, i.p.). Anesthesia 
was induced and maintained with 0.5%–3% inhaled isoflurane. A mid-
line skin incision was made over the skull, 4 holes were drilled into the 
skull, and a headmount was attached with two 0.1-inch (anterior) and 
two 0.125-inch (posterior) stainless steel machine screws (0.8 × 4.2; 
stainless steel nose pad screw; QTE North America Inc.). EMG leads 
extending from the posterior portion of the headmount were sutured 
into nuchal muscles bilaterally 3 mm from midline. ECG leads were 
tunneled under the skin and sutured to the anterior thoracic wall in an 
approximate lead II configuration. The base of the headmount, screw 
heads, and EMG and ECG leads were anchored with dental acrylic (Jet 
Acrylic; Lang Dental) and the skin was sutured closed leaving only the 
headmount socket exposed. Temperature/activity telemetry probes 
(G2 E-Mitter; Mini-Mitter Inc.) were inserted into the peritoneal cav-
ity to measure body temperature as previously described (77). A ster-
ile surgical prep was made on the abdomen, and temperature probes 
were inserted into the peritoneum through a midline incision. The 
incision was closed with suture or Vetbond (3M Animal Care Product). 
Animals received postoperative analgesia with meloxicam (0.5 mg/
kg, i.p.) or buprenorphine (0.1 mg/kg, i.p.) for 3 days and were allowed 
to recover for at least 5 days before recordings were made.
Long-term, continuous mouse EMU/plethysmography data acquisi-
tion. A preamplifier (8406-SE31M-C; Pinnacle Technology Inc.) was 
inserted into the implanted headmount connector for recording EEG, 
ECG, and EMG (gain ×10; high pass filter for ECG 0.5 Hz; EEG 1 Hz; 
EMG 10 Hz). The animal was placed into a mouse EMU/plethysmog-
raphy chamber custom-designed and built to comply with require-
ments for continuous housing described in the Guide for the Care and 
Use of Laboratory Animals (78). The floor was circular and 5 inches in 
diameter. The walls were semiconical with a roof that was 5.5 inches 
high and 3 inches in diameter. The chamber volume was 815 ml. There 
were ports for air in and air out, and for pressure and temperature/
humidity monitoring. The chamber was supplied with a continuous 
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Exposure to hypoxia. Scn1aR1407X/+ mice and WT littermates were 
instrumented with ECG leads and temperature probes as above. After 
at least 5 days of recovery, mice were placed in a plethysmography 
chamber where the ECG and body temperature were continuously 
monitored. The chamber was flushed with gas flowing at 700 ml/min, 
first with medical grade 21% O2/79% N2/1% isoflurane. After estab-
lishing a baseline, the gas was switched to 100% N2/1% isoflurane. 
Isoflurane levels were maintained at 1% using a precision vaporizer 
(Summit Anesthesia Solutions). The time course for the change of PO2 
was measured using an O2 analyzer (Model S-3A; AEI Technologies) 
in a separate set of experiments without isoflurane to avoid damage to 
the O2 analyzer. Mice were studied either with or without injection of 
atropine (1 mg/kg, i.p.) 30 minutes before exposure to anoxia. Control 
mice were injected with the same volume of saline solution. The pleth-
ysmography chamber was maintained at 30°C using a heat lamp and 
feedback controller (TCAT-2AC; Physitemp Instruments).
Data analysis and statistics. Time-frequency power spectrum anal-
ysis was performed with MATLAB based on a short-time fast Fourier 
transform. The time-dependent power spectrum density of the signal 
was computed and displayed with discrete-time epochs calculated 
for 0.5-second intervals. Sections overlapped by 20% to smooth the 
signal. The ECG sampling rate was 1 kHz, whereas EEG, EMG, and 
plethysmography were sampled at 100 Hz.
Analyses of respiratory rate and heart rate were performed using 
software custom written in MATLAB and/or Clampfit Software 
(Molecular Devices). Inspiratory peaks were detected automatically 
from plethysmography data by applying a bandpass filter of 1–10 Hz 
and using peak detection verified manually. R-wave detection of ECG 
data was performed by applying a continuous wavelet transform and 
peak detection in MATLAB. The time interval between breath peaks 
(interbreath interval) and the R-R interval from detected R waves were 
computed as the mean for 10-second epochs.
Abnormal breathing in patients with DS was compared with 
breathing in patients with localization-related epilepsy (Table 1) using 
a χ2 test. Severity of seizures was measured by computing the mean 
EEG intensity from power spectra generated using MATLAB. Statisti-
cal comparisons of seizure severity and duration, and Poincarè plots 
(SD1 and SD2), were made using a Mann-Whitney U test with an over-
all significance level set to P < 0.05 (GraphPad Prism V6.01). When 
data are presented as X ± Y, X is the group mean and Y is the standard 
deviation. All error bars on graphs represent the SEM.
Clinical phenotype of a patient with DS with prolonged postictal 
hypoventilation. The patient shown in Figure 2 had her first seizure 
at 5.5 months of age. Seizure types prior to the EMU admission had 
included generalized convulsions, hemiconvulsions, partial seizures 
with variable semiology, atypical absence seizures, and myoclonic 
jerks. At the time of EMU admission, seizure types included (a) feel-
ing “spacey” for 5–10 seconds with blank staring, slackening of facial 
muscles, and slurred speech, and (b) repetitive asynchronous general-
ized convulsions in series lasting 1–2 minutes each, interrupted by a 
fixed gaze for up to 5 minutes. The patient’s seizures had worsened 
in frequency and severity during the previous 6 months. There was 
concern for a decrease in alertness and cognitive ability. The EMU 
study was performed to assess EEG background activity and to clarify 
the types of seizures. The patient was treated at the time of admission 
with levetiracetam, clobazam, stiripentol, and a ketogenic diet. The 
first event for the episode shown in Figure 2 began off camera in the 
Heat-induced seizures in mice. Mice were instrumented with 
headmounts and telemetry probes to allow recordings of all the sig-
nals described for monitoring spontaneous deaths. After at least 5 
days, mice were lightly anesthetized with 1% isoflurane for 1–2 min-
utes to connect a preamplifier to the headmount. Any experimen-
tal drugs were injected at that time. Mice were then placed in the 
plethysmography chamber and allowed to recover from anesthesia 
and acclimate for 30 minutes. Seizures were then induced by hyper-
thermia using a protocol previously reported for a DS mouse model 
(40). Using a heat lamp, body temperature in Scn1aR1407X/+ mice and 
WT littermates was increased from 36°C to 42.5°C at a rate of 0.5°C 
per minute or until a generalized seizure with tonic hind limb exten-
sion was induced. To maximize the amplitude of the breathing sig-
nal, the plethysmography chamber was maintained at 25°C–27°C 
by a thermodynamic cooling system made in-house that cooled the 
incoming air. In some cases mice were resuscitated after a seizure 
by placing Tygon tubing (United States Plastic Corp.) over the snout 
and inflating the lungs with air using a mechanical ventilator (Mini-
Vent type 845; Harvard Apparatus).
Effect of muscarinic receptor antagonists on bradycardia. To deter-
mine the role of parasympathetic output in postictal bradycardia, 
muscarinic receptor antagonists were administered 30 minutes prior 
to heat-induced seizures. All antagonists given via i.p. injection were 
dissolved in a volume of 50 μl in bacteriostatic 0.9% NaCl solution. 
In a separate set of experiments, N-methylscopolamine was given 
via injection into the lateral ventricle dissolved to a volume of 50 nl 
in artificial cerebrospinal fluid (aCSF) containing 125 mM NaCl, 5.0 
mM KCl, 24 mM NaHCO3, 1.25 mM KH2PO4, 0.8 mM CaCl2, 1.25 
mM MgSO4, and 30 mM glucose. Coordinates used for i.c.v. injection 
were 0 mm AP to bregma, 1.0 mm lateral, and 2.5 mm below the skull 
surface. Atropine, methylatropine nitrate, and N-methylscopolamine 
bromide were obtained from Sigma-Aldrich. At a dose of 1 mg/kg 
(i.p.), atropine had no effect on the likelihood of Racine scale 5 sei-
zures, or the duration or severity of seizures based on EEG analysis. 
In the cohort of control mice shown in Figure 5A for fatal seizures (n = 
7), seizure duration was 25.7 ± 9.2 seconds and the mean EEG power 
between 0.5 and 20 Hz (as a measure of seizure severity) was 0.083 ± 
0.026 s–1. In contrast, for the mice treated with atropine shown in Fig-
ure 5A for nonfatal seizures (n = 14 seizures), seizure duration was 21.9 
± 8.3 seconds and the mean EEG power was 0.121 ± 0.055 s–1. These 
differences were not statistically significant (P > 0.05; Mann-Whitney 
U test). After treatment with atropine (1 mg/kg, i.p.) or N-methylsco-
polamine (0.3 μg/kg, i.c.v.), some seizures were characterized by clon-
ic limb contractions instead of tonic hind limb extension, although in 
both cases they met criteria for Racine scale 5 seizures.
HRV was assessed using Poincaré plots (65) before and 30 min-
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(SD1). HRV is primarily due to vagus nerve–mediated parasympathetic 
inhibition of the sinoatrial node (60–65). For all Poincaré plots, 500 
pairs of R-R intervals were plotted and analyzed at baseline and after 
drug injection. Data were not analyzed during any animal movements 
to eliminate artifacts.
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